Try our Advanced Search for more refined results
USA v. Cadden et al
Case Number:
1:14-cr-10363
Court:
Nature of Suit:
Judge:
Firms
- Anderson & Kreiger
- Brody Hardoon
- Butters Brazilian
- Commisso Law
- Fitch Law Partners
- Greenberg Traurig
- Hinckley Allen
- Holland & Knight
- Husch Blackwell
- Jackson Lewis PC
- Kiernan Trebach
- Krattenmaker O'Connor
- Laredo & Smith
- Law Offices of Stephen J. Weymouth
- Libby Hoopes
- McDermott Will & Emery
- Michaels Ward
- Murphy & King
- Prince Lobel
- Todd & Weld
- Troutman Pepper
- WilmerHale
-
March 01, 2019
Convicted NECC Pharmacists Can Make Case For Acquittal
A Massachusetts federal judge has agreed to an acquittal hearing for two former New England Compounding Center employees, days after two others argued to scrap their recent convictions for failures at the pharmacy, which was blamed for a nationwide meningitis outbreak in 2012.
-
February 26, 2019
NECC Execs Say Conspiracy Convictions 'Legally Impossible'
Two former executives at the New England Compounding Center asked a Massachusetts federal judge Tuesday to nullify their convictions for conspiracy to defraud the U.S. Food and Drug Administration, saying the crime was "legally impossible."
-
December 13, 2018
5 Of 6 NECC Defendants Guilty In Latest Trial
A jury found five of six former New England Compounding Center employees guilty Thursday morning after a week of deliberations in Boston federal court in the third criminal trial related to the Framingham, Massachusetts, facility, whose contaminated steroids killed 64 and infected almost 800 others in a nationwide meningitis outbreak in 2012.
-
December 04, 2018
6 NECC Workers Had Role In Drug Fraud, Feds Say In Closing
Prosecutors on Tuesday urged a jury after seven weeks of testimony to convict six former employees of the Massachusetts compounding pharmacy whose steroids sparked a deadly meningitis outbreak in 2012, saying they participated in a scheme to defraud federal regulators and ship out unsafe drugs to medical facilities around the country.
-
November 19, 2018
FDA Was In The Dark About NECC Misconduct, Official Says
The top drug regulator for the U.S. Food and Drug Administration testifying in the trial of a compounding pharmacy's six former employees told a Boston federal jury Monday that the agency did not fully understand the danger posed by the pharmacy, whose contaminated steroids led to a national meningitis outbreak in 2012.
-
October 22, 2018
NECC Pharmacy Tech Testifies About Hijinks In Drug Lab
A whistleblower who worked at the New England Compounding Center in Massachusetts before it was blamed for a deadly meningitis outbreak and closed in 2012 testified in federal court Monday that he and his colleagues routinely signed off on drug shipments when they knew ingredients were expired or had not been tested.
-
October 19, 2018
Fake Patient Names Take Center Stage At 3rd NECC Trial
In the first week of a trial in Massachusetts federal court for six former employees of the New England Compounding Center, whose contaminated drugs sparked a deadly meningitis outbreak in 2012, the question of who bears responsibility for fake patient names used on prescription order forms has been a daily point of contention.
-
October 18, 2018
Jury Told Of Seized Drugs, Unsafe Workplace At NECC Trial
A prosecutor wearing purple protective gloves in Massachusetts federal court on Thursday presented a series of apparently expired drugs seized from the New England Compounding Center in 2012 as the government tried to build its case that the facility's operations were sloppy and unsafe before a deadly meningitis outbreak that killed dozens of people.
-
October 15, 2018
Ex-NECC Workers Blame Boss In Fraud Case
Attorneys for six former New England Compounding Center employees accused of misleading regulators about the workings of the facility whose tainted drugs caused a deadly meningitis outbreak placed the blame on the workers' boss in statements to a Boston federal jury Monday.
-
October 11, 2018
Ex-NECC Owner's Income Fair Game At Meningitis Trial
Federal prosecutors can tell a Boston jury about the income of a former part-owner and director of the shuttered New England Compounding Center linked to a fatal outbreak of fungal meningitis, a judge ruled Thursday, denying his motion that argued the information would appeal to jurors' class bias in the trial of six NECC employees that begins Monday.